Tx. Pharmacy Board Backs Off on Restricting HCQ Prescriptions
Written by Kim Roberts
The Texas State Board of Pharmacy issued a new rule that no prescriptions for hydroxychloroquine could be dispensed without a diagnosis, then changed their tune.
Dr. Ivette Lozano, who has been in medical practice for over 20 years, was shocked to learn in March that she would be required to share her patient’s diagnosis with the pharmacist before prescriptions for hydroxychloroquine and azithromycin would be dispensed.
On March 20, the Texas State Board of Pharmacy issued a new rule that no prescriptions for hydroxychloroquine or azithromycin could be dispensed without a diagnosis “consistent with evidence for its use.”
“Never before have we had to turn in a diagnosis with a prescription,” Lozano told The Texan. Lozano has seen about five to six patients per week for coronavirus. “They see a dramatic improvement within six to eight hours,” Lozano said.
Dr Lozano video below – she explains to gathered crowd:
Health care attorney Matt Rinaldi said doctors have called him concerned about the requirement. He said the rule does not violate HIPAA regulations because patient information can be shared for treatment purposes.
Read more at thetexan.news
PRINCIPIA SCIENTIFIC INTERNATIONAL, legally registered in the UK as a company incorporated for charitable purposes. Head Office: 27 Old Gloucester Street, London WC1N 3AX.